Trial Profile
The effectiveness of intensive treatment on sympathetic hyperactivity. A randomized, cross-over trial in patients with chronic kidney disease and hypertension.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Jul 2011
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 06 Jul 2011 New trial record